Multiple Sclerosis and CNS Inflammatory Disorders 2014
DOI: 10.1002/9781118298633.ch1
|View full text |Cite
|
Sign up to set email alerts
|

Etiology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2018
2018

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…It is estimated that 2.3 million people worldwide have MS with the highest prevalence rates reported in North America and Europe [1] . The etiology of MS is not fully understood, involving autoimmune mechanisms in genetically susceptible individuals [2] . The prevalence of arthritic comorbidity among persons with MS is still an evolving area of research and is estimated to be in the range of 16%-26% [3] , [4] .…”
Section: Introductionmentioning
confidence: 99%
“…It is estimated that 2.3 million people worldwide have MS with the highest prevalence rates reported in North America and Europe [1] . The etiology of MS is not fully understood, involving autoimmune mechanisms in genetically susceptible individuals [2] . The prevalence of arthritic comorbidity among persons with MS is still an evolving area of research and is estimated to be in the range of 16%-26% [3] , [4] .…”
Section: Introductionmentioning
confidence: 99%